Get started
MARKER THERAPEUTICS INCMARKER THERAPEUTICS INCMARKER THERAPEUTICS INC

MARKER THERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

GX1 chart


Full chart

GX1 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.25 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.23 EUR
Net income (FY)
‪−10.37 M‬ EUR
Revenue (FY)
‪6.37 M‬ EUR
Shares float
‪7.90 M‬
Beta (1Y)
1.55

Employees


Employees (FY)
5
Change (1Y)
−3 −37.50%
Revenue / Employee (1Y)
‪1.27 M‬ EUR
Net income / Employee (1Y)
‪−2.07 M‬ EUR

About Marker Therapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Juan F. Vera
Website
markertherapeutics.com
Headquarters
Houston
Founded
1991
FIGI
BBG000GQF329
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GX1 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as GX1.

Frequently Asked Questions


The current price of GX1 is 0.98 EUR — it has increased by 1.04% in the past 24 hours. Watch MARKER THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MARKER THERAPEUTICS INC stocks are traded under the ticker GX1.
GX1 stock has risen by 8.33% compared to the previous week, the month change is a 23.42% rise, over the last year MARKER THERAPEUTICS INC has showed a −55.23% decrease.
We've gathered analysts' opinions on MARKER THERAPEUTICS INC future price: according to them, GX1 price has a max estimate of 11.55 EUR and a min estimate of 3.70 EUR. Watch GX1 chart and read a more detailed MARKER THERAPEUTICS INC stock forecast: see what analysts think of MARKER THERAPEUTICS INC and suggest that you do with its stocks.
GX1 reached its all-time high on Dec 17, 2024 with the price of 5.25 EUR, and its all-time low was 0.58 EUR and was reached on Apr 7, 2025. View more price dynamics on GX1 chart.
See other stocks reaching their highest and lowest prices.
GX1 stock is 1.03% volatile and has beta coefficient of 1.55. Track MARKER THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is MARKER THERAPEUTICS INC there?
Today MARKER THERAPEUTICS INC has the market capitalization of ‪11.17 M‬, it has increased by 3.86% over the last week.
Yes, you can track MARKER THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
MARKER THERAPEUTICS INC is going to release the next earnings report on Aug 18, 2025. Keep track of upcoming events with our Earnings Calendar.
GX1 net income for the last quarter is ‪−4.11 M‬ EUR, while the quarter before that showed ‪−3.71 M‬ EUR of net income which accounts for −10.86% change. Track more MARKER THERAPEUTICS INC financial stats to get the full picture.
No, GX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 20, 2025, the company has 5 employees. See our rating of the largest employees — is MARKER THERAPEUTICS INC on this list?
Like other stocks, GX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARKER THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MARKER THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MARKER THERAPEUTICS INC stock shows the sell signal. See more of MARKER THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.